Recurrence of hypertension is reported in a considerable percentage of renovascular hypertensive patients treated by percutaneous transluminal angioplasty (PTRA); among the possible mechanisms for these failures, restenosis of the renal artery is the only correctable one. Since captopril stimulates renin secretion to a greater extent in renovascular than in essential hypertensive patients, we determined if it could be used to unmask significant restenosis in the patients with hypertension recurring after PTRA. Follow-up study was performed in 28 patients treated with PTRA. We found that captopril caused a greater increase in peripheral plasma renin activity in 8 of 8 cases who had recurrence of hypertension and restenosis than in 13 of 15 of the patients who did not. We suggest that the determination of captopril-stimulated renin may provide a useful, simple and economical tool for the detection of restenosis after PTRA. © 1986, International Heart Journal Association. All rights reserved.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Rossi, G. P., Pessina, A. G., Semplicini, A., Mozzato, M. G., Dissegna, L., Palu, C. D., & Feltrin, G. (1986). Captopril-stimulated Renin in the Diagnosis of Restenosis after Percutaneous Transluminal Renal Angioplasty. Japanese Heart Journal, 27(3), 299–305. https://doi.org/10.1536/ihj.27.299